Eli Lilly
-
Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDAThe U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.HealthMar 8
-
Eli Lilly’s new version of diabetes drug Mounjaro approved for weight loss by FDAA new version of the popular diabetes treatment Mounjaro from Eli Lilly can be sold as a weight-loss drug, U.S. regulators announced Wednesday.HealthNov 8, 2023
-
-
Advertisement
-
Alzheimer’s drug slows progression in patients. It may soon be approved in U.S.Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.HealthJul 17, 2023
-
-
Advertisement
-
No insulin price cut coming for Canada despite U.S. slashes, Eli Lilly saysEli Lilly and Co. announced Wednesday that it will cut prices for some of its most commonly prescribed insulin products in the United States.CanadaMar 3, 2023
-
Drugmaker Eli Lilly slashes prices, will offer $35 insulin in U.S. pharmaciesIn addition to slashing some drug prices by 70 per cent, Eli Lilly also promised to expand an existing program that caps some insulin products at $50.U.S. NewsMar 1, 2023
-
-
FDA authorizes new antibody drug that targets Omicron COVID-19 variantThe Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.WorldFeb 11, 2022
-
-
U.S. limits use of Regeneron, Eli Lilly COVID-19 antibody treatments amid Omicron spreadLast month, the U.S. had paused the distribution of Regeneron and Lilly's treatments and said the halt would continue until new data emerges on their efficacy against Omicron.HealthJan 24, 2022
-
Standard drugs used to fight COVID-19 may not work against Omicron: U.S. doctorsThe shrinking toolbox of treatments is a painful reminder that COVID-19 still has the upper hand in the U.S., even with more than 200 million Americans fully vaccinated.HealthDec 19, 2021
-
-
Advertisement
-
U.S. drugmaker Lilly to submit ‘breakthrough’ Alzheimer’s drug to FDAThe drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.HealthJun 24, 2021
-
-
Advertisement
-
B.C. to start clinical trials for previously rejected COVID-19 treatmentVancouver-based biotech firm AbCellera has donated $1 million to the province to support the clinical trials.HealthFeb 9, 2021
Trending
-
‘FLiRT’ COVID-19 subvariant dominant in Canada. What to know about the strain6,814 Read
-
Northern lights could appear across Canada as ‘severe’ geomagnetic storm nears6,157 Read
-
Man charged in surfer deaths told girlfriend he killed ‘3 gringos,’ court hears2,189 Read
-
A look at the twisted crimes of Peter Demeter, one of Canada’s worst criminals1,690 Read
-
Hailey Bieber pregnant, expecting 1st baby with Justin Bieber1,291 Read
-
Reducing temporary visas may include offering permanent residency: Miller1,004 Read
-
Top Videos
-
Health Matters: China froze COVID-19 origin tracing, AP investigation finds
-
Northern lights could appear across Canada as ‘severe’ geomagnetic storm nears
-
Missing Australian, American surfers found dead in well after ‘attempted carjacking’ in Mexico
-
Crime Beat: The Death of Christine Demeter (teaser)
-
Hailey Bieber pregnant, expecting 1st baby with Justin Bieber
-